ECElena Crestani

Elena Crestani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena Crestani has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance

    by Rima Rachid, Monica Martinez-Blanco, Gavin A. Kuziel, Emmanuel Stephen-Victor, Mathieu Groussin, Askarbek Orakov, George Russell, Le Thanh Tu Nguyen, Mathilde Poyet, Zhussipbek Mukhatayev, et al.

    The gut microbiome has been implicated in the pathogenesis of food allergy (FA), prompting microbiome-focused interventions. We evaluated, in a phase 1 open-label trial (NCT02960074), the safety and efficacy of oral encapsulated fecal microbiome transplantation (FMT) in 15 adults with peanut allergies. An increase in the peanut reactivity threshold was noted in 3 of 10 participants not pretreated with antibiotics and 3 of 5 participants pretreated with antibiotics, without safety issues. In responders, FMT increased tolerogenic RORγt + regulatory T cells (T reg cells) and decreased T helper 2 cells (T H 2 cells). Mice transplanted with the microbiomes of post-FMT responders were protected from FA in association with increased RORγt + T reg cell percentages and increased colonization with members of the gut Bacteroides . In both humans and mice, protection by FMT was associated with increased bile acid metabolites. Deletion of a bile salt hydrolase in a candidate protective Bacteroides abrogated FA suppression in mice. These results suggest that FMT is a safe and potentially promising therapeutic modality for treating FA.


  • Metabolomic and immunological signatures of asthma severity in children

    by Elena Crestani, Hani Harb, Mehdi Benamar, Rima Kaddurah‐Daouk, Wanda Phipatanakul, Talal A. Chatila

    Background: Multiple risk factors for asthma severity have been identified by epidemiological studies. Yet, the pathophysiological mechanisms driving the severity of clinical asthma manifestations remain incompletely understood. In asthmatic children, Notch4 expression on circulating Treg cells and levels of circulating GDF15 have been shown to be increased as a function of disease severity, suggesting a contribution of Treg dysfunction to disease phenotype. Methods: 126 children with asthma (intermittent = 40; mild persistent = 43; moderate persistent = 29, and severe persistent = 14) and 83 non‐asthmatic controls were recruited in the Allergy clinic at Boston Children's Hospital and from asthma cohorts. Untargeted metabolomic analysis and cytokine profiling were performed in plasma and results correlated with disease severity, Notch4 expression, and presence of other atopic comorbidities. Results: Children with moderate/severe asthma had higher levels of select lipids (triglycerides, ceramides) and carboxylic acids (lactic acid, aconitic acid) and lower levels of amino acids (sarcosine and arginine) and of IFNλ 2/3 compared to children with intermittent/mild asthma. Treg Notch4 expression and GDF15 levels, which increase with disease severity, correlated positively with lactic acid and xanthine levels and inversely with sarcosine and arginine. The concomitant presence of food allergy was associated with alterations in microbiome‐related metabolites and allergic rhinitis with marked triglyceride dysregulation. Conclusions: Untargeted metabolomic profiling identified both shared and unique pathways associated with known asthma severity contributors, Notch4 dysregulation and GDF15 elevation, suggesting that different mechanisms may both converge or independently contribute to determining clinical manifestations of asthma severity in asthmatic children.


  • RELMβ sets the threshold for microbiome-dependent oral tolerance

    by Emmanuel Stephen-Victor, Gavin A. Kuziel, Monica Martinez-Blanco, Bat-Erdene Jugder, Mehdi Benamar, Ziwei Wang, Qian Chen, Gabriel L. Lozano, Azza Abdel-Gadir, Ye Cui, et al.

    Tolerance to dietary antigens is critical for avoiding deleterious type 2 immune responses resulting in food allergy (FA) and anaphylaxis1,2. However, the mechanisms resulting in both the maintenance and failure of tolerance to food antigens are poorly understood. Here we demonstrate that the goblet-cell-derived resistin-like molecule β (RELMβ)3,4 is a critical regulator of oral tolerance. RELMβ is abundant in the sera of both patients with FA and mouse models of FA. Deletion of RELMβ protects mice from FA and the development of food-antigen-specific IgE and anaphylaxis. RELMβ disrupts food tolerance through the modulation of the gut microbiome and depletion of indole-metabolite-producing Lactobacilli and Alistipes. Tolerance is maintained by the local production of indole derivatives driving FA protective RORγt+ regulatory T (Treg) cells5 through activation of the aryl hydrocarbon receptor. RELMβ antagonism in the peri-weaning period restores oral tolerance and protects genetically prone offspring from developing FA later in life. Together, we show that RELMβ mediates a gut immune–epithelial circuit regulating tolerance to food antigens—a novel mode of innate control of adaptive immunity through microbiome editing—and identify targetable candidates in this circuit for prevention and treatment of FA.


  • Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections

    by Hani Harb, Mehdi Benamar, Peggy S. Lai, Paola Contini, Jason W. Griffith, Elena Crestani, Klaus Schmitz-Abe, Qian Chen, Jason Fong, Luca Marri, et al.


  • Top Cited Papers

    Regulatory T Cell-Derived TGF-β1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity

    by Jacob A. Turner, Emmanuel Stephen-Victor, Sen Wang, Magali Noval Rivas, Azza Abdel-Gadir, Hani Harb, Ye Cui, Manoussa Fanny, Louis-Marie Charbonnier, Jason Jun Hung Fong, et al.


  • Dietary and Microbial Determinants in Food Allergy

    by Emmanuel Stephen-Victor, Elena Crestani, Talal A. Chatila


  • Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly

    by Ali Sobh, Elena Crestani, Brittney Cangemi, Jennifer Kane, Janet Chou, Sung-Yun Pai, Luigi D. Notarangelo, Waleed Al-Herz, Raif S. Geha, Michel J. Massaad